These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11031411)

  • 21. Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir.
    Chhetri DK; Blumin JH; Shapiro NL; Berke GS
    Otolaryngol Head Neck Surg; 2002 Jun; 126(6):642-8. PubMed ID: 12087331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
    Pudszuhn A; Welzel C; Bloching M; Neumann K
    Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional cidofovir in severe juvenile respiratory papillomatosis.
    Ablanedo-Terrazas Y; Soda-Merhy A; Hernández-Palestina M; Ormsby CE; Reyes-Terán G
    B-ENT; 2012; 8(3):197-202. PubMed ID: 23113383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
    McMurray JS; Connor N; Ford CN
    Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
    Co J; Woo P
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
    Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
    J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
    Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
    Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment for laryngeal papillomatosis.
    Kendall KA
    Curr Opin Otolaryngol Head Neck Surg; 2004 Jun; 12(3):157-9. PubMed ID: 15167022
    [No Abstract]   [Full Text] [Related]  

  • 30. Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.
    Naiman AN; Abedipour D; Ayari S; Fresnel E; Coulombeau B; Bour JB; Froehlich P
    Ann Otol Rhinol Laryngol; 2006 Mar; 115(3):175-81. PubMed ID: 16572605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
    Schraff S; Derkay CS; Burke B; Lawson L
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
    Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
    Coulombeau B; Nusa Naiman A; Ceruse P; Froehlich P
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(5):315-20. PubMed ID: 12741293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report.
    Wilson WR; Hashemiyoon R; Hawrych A
    Ear Nose Throat J; 2000 Apr; 79(4):236-8, 240. PubMed ID: 10786384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic cidofovir in papillomatosis.
    Van Valckenborgh I; Wellens W; De Boeck K; Snoeck R; De Clercq E; Feenstra L
    Clin Infect Dis; 2001 Feb; 32(3):E62-4. PubMed ID: 11170974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.
    Dikkers FG
    Eur Arch Otorhinolaryngol; 2006 May; 263(5):440-3. PubMed ID: 16328406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
    Broekema FI; Dikkers FG
    Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.